Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Instead of following the standard FDA titration schedule, they start with even smaller semaglutide doses and increase more gradually
According to the FDA's official guidance (updated April 2026 at fda.gov), the semaglutide injection shortage was resolved on February 21, 2025, and the transitional exemption windows for compounders operating under the shortage exemption subsequently ended - for 503A pharmacies by April 22, 2025, and for 503B outsourcing facilities by May 22, 2025
Severe, long-standing damage may take longer or may be permanent, which is why early treatment matters
References used in this article: National Institutes of Health (NIH) Glucagon-Like Peptide-1 Receptor Agonists: Diabetes Australia GLP-1 receptor agonists and diabetes managementhttps: www.diabetesaustralia.com.au/medication/glp-1-receptor-agonists/ The Lancet Once-weekly semaglutide in adults with overweight or obesityhttps: www.thelancet.com/article/S0140-6736(21)00213-0/fulltext Endocrine Society Pharmacological Management of Obesity: An Endocrine Society Guidelinehttps: academic.oup.com/jcem/article/105/12/3938/5919133 The New England Journal of Medicine (NEJM) Semaglutide Treatment Effect in People with Obesity (STEP trials)
US$ 20.96
US$ 26.07
US$ 28.82
US$ 29.23
US$ 28.61
US$ 29.32
